0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Rheumatoid Arthritis Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-29N5788
Home | Market Reports | Health| Health Conditions| Arthritis
Global Rheumatoid Arthritis Diagnostic Tests Market Insights Forecast to 2028
BUY CHAPTERS

Rheumatoid Arthritis Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-29N5788
Report
November 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rheumatoid Arthritis Diagnostic Tests - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rheumatoid Arthritis Diagnostic Tests - Market

Rheumatoid Arthritis Diagnostic Tests - Market

Rheumatoid arthritis (RA) is an autoimmune disease in which the body’s own immune system attacks its joint tissues, which leads to inflammation of joint lining. Such inflammation of joint lining causes pain, stiffness, swelling, warmth, and redness.
The global market for Rheumatoid Arthritis Diagnostic Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Diagnostic Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rheumatoid Arthritis Diagnostic Tests by region & country, by Type, and by Application.
The Rheumatoid Arthritis Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Diagnostic Tests.
Market Segmentation

Scope of Rheumatoid Arthritis Diagnostic Tests - Market Report

Report Metric Details
Report Name Rheumatoid Arthritis Diagnostic Tests - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Diagnostics, Beckman Coulter, Euro Diagnostica, Hoffmann-La Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio Rad Laboratories, Aviva Systems Biology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Rheumatoid Arthritis Diagnostic Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Rheumatoid Arthritis Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Rheumatoid Arthritis Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Rheumatoid Arthritis Diagnostic Tests - Market report?

Ans: The main players in the Rheumatoid Arthritis Diagnostic Tests - Market are Abbott Diagnostics, Beckman Coulter, Euro Diagnostica, Hoffmann-La Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio Rad Laboratories, Aviva Systems Biology

What are the Application segmentation covered in the Rheumatoid Arthritis Diagnostic Tests - Market report?

Ans: The Applications covered in the Rheumatoid Arthritis Diagnostic Tests - Market report are Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, Others

What are the Type segmentation covered in the Rheumatoid Arthritis Diagnostic Tests - Market report?

Ans: The Types covered in the Rheumatoid Arthritis Diagnostic Tests - Market report are Serology Tests, Monitoring RA Treatment Efficiency Tests

Recommended Reports

In Vitro Diagnostics

Virus and Rapid Testing

Autoimmune & Specialized Tests

1 Market Overview
1.1 Rheumatoid Arthritis Diagnostic Tests Product Introduction
1.2 Global Rheumatoid Arthritis Diagnostic Tests Market Size Forecast
1.3 Rheumatoid Arthritis Diagnostic Tests Market Trends & Drivers
1.3.1 Rheumatoid Arthritis Diagnostic Tests Industry Trends
1.3.2 Rheumatoid Arthritis Diagnostic Tests Market Drivers & Opportunity
1.3.3 Rheumatoid Arthritis Diagnostic Tests Market Challenges
1.3.4 Rheumatoid Arthritis Diagnostic Tests Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rheumatoid Arthritis Diagnostic Tests Players Revenue Ranking (2023)
2.2 Global Rheumatoid Arthritis Diagnostic Tests Revenue by Company (2019-2024)
2.3 Key Companies Rheumatoid Arthritis Diagnostic Tests Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rheumatoid Arthritis Diagnostic Tests Product Offered
2.5 Key Companies Time to Begin Mass Production of Rheumatoid Arthritis Diagnostic Tests
2.6 Rheumatoid Arthritis Diagnostic Tests Market Competitive Analysis
2.6.1 Rheumatoid Arthritis Diagnostic Tests Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Rheumatoid Arthritis Diagnostic Tests Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Diagnostic Tests as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Serology Tests
3.1.2 Monitoring RA Treatment Efficiency Tests
3.2 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Type
3.2.1 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rheumatoid Arthritis Diagnostic Tests Sales Value, by Type (2019-2030)
3.2.3 Global Rheumatoid Arthritis Diagnostic Tests Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostic Laboratories
4.1.2 Ambulatory Surgical Centers
4.1.3 Hospitals
4.1.4 Others
4.2 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Application
4.2.1 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rheumatoid Arthritis Diagnostic Tests Sales Value, by Application (2019-2030)
4.2.3 Global Rheumatoid Arthritis Diagnostic Tests Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region
5.1.1 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region (2019-2024)
5.1.3 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region (2025-2030)
5.1.4 Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
5.2.2 North America Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
5.3.2 Europe Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
5.4.2 Asia Pacific Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
5.5.2 South America Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
5.6.2 Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rheumatoid Arthritis Diagnostic Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rheumatoid Arthritis Diagnostic Tests Sales Value
6.3 United States
6.3.1 United States Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
6.3.2 United States Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rheumatoid Arthritis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
6.4.2 Europe Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rheumatoid Arthritis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
6.5.2 China Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rheumatoid Arthritis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
6.6.2 Japan Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rheumatoid Arthritis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
6.7.2 South Korea Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rheumatoid Arthritis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
6.8.2 Southeast Asia Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rheumatoid Arthritis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019-2030
6.9.2 India Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rheumatoid Arthritis Diagnostic Tests Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Diagnostics
7.1.1 Abbott Diagnostics Profile
7.1.2 Abbott Diagnostics Main Business
7.1.3 Abbott Diagnostics Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.1.4 Abbott Diagnostics Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Diagnostics Recent Developments
7.2 Beckman Coulter
7.2.1 Beckman Coulter Profile
7.2.2 Beckman Coulter Main Business
7.2.3 Beckman Coulter Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.2.4 Beckman Coulter Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.2.5 Beckman Coulter Recent Developments
7.3 Euro Diagnostica
7.3.1 Euro Diagnostica Profile
7.3.2 Euro Diagnostica Main Business
7.3.3 Euro Diagnostica Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.3.4 Euro Diagnostica Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.3.5 Hoffmann-La Roche Recent Developments
7.4 Hoffmann-La Roche
7.4.1 Hoffmann-La Roche Profile
7.4.2 Hoffmann-La Roche Main Business
7.4.3 Hoffmann-La Roche Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.4.4 Hoffmann-La Roche Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.4.5 Hoffmann-La Roche Recent Developments
7.5 Qiagen
7.5.1 Qiagen Profile
7.5.2 Qiagen Main Business
7.5.3 Qiagen Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.5.4 Qiagen Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.5.5 Qiagen Recent Developments
7.6 Siemens Healthcare
7.6.1 Siemens Healthcare Profile
7.6.2 Siemens Healthcare Main Business
7.6.3 Siemens Healthcare Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.6.4 Siemens Healthcare Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.6.5 Siemens Healthcare Recent Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Profile
7.7.2 Thermo Fisher Scientific Main Business
7.7.3 Thermo Fisher Scientific Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.7.4 Thermo Fisher Scientific Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.7.5 Thermo Fisher Scientific Recent Developments
7.8 Bio Rad Laboratories
7.8.1 Bio Rad Laboratories Profile
7.8.2 Bio Rad Laboratories Main Business
7.8.3 Bio Rad Laboratories Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.8.4 Bio Rad Laboratories Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.8.5 Bio Rad Laboratories Recent Developments
7.9 Aviva Systems Biology
7.9.1 Aviva Systems Biology Profile
7.9.2 Aviva Systems Biology Main Business
7.9.3 Aviva Systems Biology Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
7.9.4 Aviva Systems Biology Rheumatoid Arthritis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.9.5 Aviva Systems Biology Recent Developments
8 Industry Chain Analysis
8.1 Rheumatoid Arthritis Diagnostic Tests Industrial Chain
8.2 Rheumatoid Arthritis Diagnostic Tests Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rheumatoid Arthritis Diagnostic Tests Sales Model
8.5.2 Sales Channel
8.5.3 Rheumatoid Arthritis Diagnostic Tests Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Rheumatoid Arthritis Diagnostic Tests Market Trends
    Table 2. Rheumatoid Arthritis Diagnostic Tests Market Drivers & Opportunity
    Table 3. Rheumatoid Arthritis Diagnostic Tests Market Challenges
    Table 4. Rheumatoid Arthritis Diagnostic Tests Market Restraints
    Table 5. Global Rheumatoid Arthritis Diagnostic Tests Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Rheumatoid Arthritis Diagnostic Tests Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Rheumatoid Arthritis Diagnostic Tests Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Rheumatoid Arthritis Diagnostic Tests Product Type
    Table 9. Key Companies Time to Begin Mass Production of Rheumatoid Arthritis Diagnostic Tests
    Table 10. Global Rheumatoid Arthritis Diagnostic Tests Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Diagnostic Tests as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Rheumatoid Arthritis Diagnostic Tests Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Rheumatoid Arthritis Diagnostic Tests Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Rheumatoid Arthritis Diagnostic Tests Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Rheumatoid Arthritis Diagnostic Tests Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region (2019-2024) & (%)
    Table 27. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Rheumatoid Arthritis Diagnostic Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Rheumatoid Arthritis Diagnostic Tests Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Diagnostics Basic Information List
    Table 32. Abbott Diagnostics Description and Business Overview
    Table 33. Abbott Diagnostics Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Abbott Diagnostics (2019-2024)
    Table 35. Abbott Diagnostics Recent Developments
    Table 36. Beckman Coulter Basic Information List
    Table 37. Beckman Coulter Description and Business Overview
    Table 38. Beckman Coulter Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Beckman Coulter (2019-2024)
    Table 40. Beckman Coulter Recent Developments
    Table 41. Euro Diagnostica Basic Information List
    Table 42. Euro Diagnostica Description and Business Overview
    Table 43. Euro Diagnostica Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Euro Diagnostica (2019-2024)
    Table 45. Euro Diagnostica Recent Developments
    Table 46. Hoffmann-La Roche Basic Information List
    Table 47. Hoffmann-La Roche Description and Business Overview
    Table 48. Hoffmann-La Roche Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Hoffmann-La Roche (2019-2024)
    Table 50. Hoffmann-La Roche Recent Developments
    Table 51. Qiagen Basic Information List
    Table 52. Qiagen Description and Business Overview
    Table 53. Qiagen Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Qiagen (2019-2024)
    Table 55. Qiagen Recent Developments
    Table 56. Siemens Healthcare Basic Information List
    Table 57. Siemens Healthcare Description and Business Overview
    Table 58. Siemens Healthcare Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Siemens Healthcare (2019-2024)
    Table 60. Siemens Healthcare Recent Developments
    Table 61. Thermo Fisher Scientific Basic Information List
    Table 62. Thermo Fisher Scientific Description and Business Overview
    Table 63. Thermo Fisher Scientific Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Thermo Fisher Scientific (2019-2024)
    Table 65. Thermo Fisher Scientific Recent Developments
    Table 66. Bio Rad Laboratories Basic Information List
    Table 67. Bio Rad Laboratories Description and Business Overview
    Table 68. Bio Rad Laboratories Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Bio Rad Laboratories (2019-2024)
    Table 70. Bio Rad Laboratories Recent Developments
    Table 71. Aviva Systems Biology Basic Information List
    Table 72. Aviva Systems Biology Description and Business Overview
    Table 73. Aviva Systems Biology Rheumatoid Arthritis Diagnostic Tests Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Rheumatoid Arthritis Diagnostic Tests Business of Aviva Systems Biology (2019-2024)
    Table 75. Aviva Systems Biology Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Rheumatoid Arthritis Diagnostic Tests Downstream Customers
    Table 79. Rheumatoid Arthritis Diagnostic Tests Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Rheumatoid Arthritis Diagnostic Tests Product Picture
    Figure 2. Global Rheumatoid Arthritis Diagnostic Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Rheumatoid Arthritis Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 4. Rheumatoid Arthritis Diagnostic Tests Report Years Considered
    Figure 5. Global Rheumatoid Arthritis Diagnostic Tests Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Rheumatoid Arthritis Diagnostic Tests Revenue in 2023
    Figure 7. Rheumatoid Arthritis Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Serology Tests Picture
    Figure 9. Monitoring RA Treatment Efficiency Tests Picture
    Figure 10. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Rheumatoid Arthritis Diagnostic Tests Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Diagnostic Laboratories
    Figure 13. Product Picture of Ambulatory Surgical Centers
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Others
    Figure 16. Global Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Rheumatoid Arthritis Diagnostic Tests Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Rheumatoid Arthritis Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Rheumatoid Arthritis Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Rheumatoid Arthritis Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Rheumatoid Arthritis Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Rheumatoid Arthritis Diagnostic Tests Sales Value (%), (2019-2030)
    Figure 29. United States Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Rheumatoid Arthritis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Rheumatoid Arthritis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Rheumatoid Arthritis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 50. Rheumatoid Arthritis Diagnostic Tests Industrial Chain
    Figure 51. Rheumatoid Arthritis Diagnostic Tests Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Osteoarthritis Pain Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20Y6853
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Regenerative Therapies for Osteoarthritis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Y13907
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Rheumatoid Arthritis Diagnosis Tests Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19O6132
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9A6304
Mon Sep 08 00:00:00 UTC 2025

Add to Cart